All Stories

  1. <i>BRCA</i> mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees

    Article • Cancer Biology and Medicine, January 2021, Tsinghua University Press

    Laura Cortesi

  2. Parp Inhibitors for the Treatment of Ovarian Cancer

    Article • Current Cancer Drug Targets, October 2018, Bentham Science Publishers

    Laura Cortesi

  3. Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories?

    Article • International Journal of Cancer, October 2018, Wiley

    Laura Cortesi

  4. Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients

    Article • Cancer Biology & Therapy, August 2018, Taylor & Francis

    Federico Piacentini, Laura Cortesi

  5. Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

    Article • Cancer Management and Research, January 2018, Dove Medical Press

    Stefania Pipitone, Federico Piacentini, Laura Cortesi

  6. Twenty-years experience withde novometastatic breast cancer

    Article • International Journal of Cancer, March 2015, Wiley

    Laura Cortesi

  7. Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years

    Article • International Journal of Cancer, September 2012, Wiley

    Laura Cortesi